On Tuesday, April 18, 2023, the Forum for Collaborative Research convened its 8th TAVI Forum meeting at the CPH Conference Center in Copenhagen, Denmark. The goal of the TAVI Forum is to advance the regulatory sciences for the treatment of TAVI and its associated morbidities by providing an independent and neutral venue for ongoing multi-stakeholder dialogue.
Materials
Presentations
Introduction and Program Overview
Welcome and Introductory Remarks
Veronica Miller, Forum for Collaborative Research
Per Ljungman, Karolinska University Hospital
Camille Kotton, Massachusetts General Hospital
Session I: CMV Working Group Discussion
Update on CMV Definitions
Per Ljungman, Karolinska University Hospital
Roy Chemaly, UT MD Anderson Cancer CenterConsiderations with CMV Definitions
Martha Fournier, Takeda Pharmaceuticals
Session II: Adenovirus Working Group Discussion
Launch of AdV Diagnostics Working Group
Thomas Lion, LabDia Labordiagnostik GmbH
Session III: CMV Immune Diagnostic Update
Immune Monitoring for CMV-Review Update
Frédérique Sauvé, McGill University
Session IV: Concluding Remarks: Next Steps
Veronica Miller, Forum for Collaborative Research
Per Ljungman, Karolinska University Hospital
Camille Kotton, Massachusetts General Hospital